GATTEX

This brand name is authorized in United States. It is also authorized in Israel.

Active ingredients

The drug GATTEX contains one active pharmaceutical ingredient (API):

1	Teduglutide UNII 7M19191IKG - TEDUGLUTIDE
	Teduglutide is an analogue of GLP-2. The naturally occurring human glucagon-like peptide-2 (GLP-2) is a peptide secreted by L cells of the intestine which is known to increase intestinal and portal blood flow, inhibit gastric acid secretion, and decrease intestinal motility. In several nonclinical studies, teduglutide has been shown to preserve mucosal integrity by promoting repair and normal growth of the intestine through an increase of villus height and crypt depth.
	Read more about Teduglutide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AX08	Teduglutide	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AX Various alimentary tract and metabolism products
Discover more medicines within A16AX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
IL	מִשְׂרַד הַבְּרִיאוּת	7377
US	FDA, National Drug Code	68875-0101